# Phase 2A Final Evidence Index

## Status

FINAL - PHASE 2A CLOSED

## Evidence Records

| ID | Artifact | Subject | Result |
| -- | -------- | ------- | ------ |
| VE-001 | `VERIFICATION_EVIDENCE_001_COMMENCEMENT.md` | Authorization, scope, and LOCKED boundary | PASS |
| VE-002 | `VERIFICATION_EVIDENCE_002_SAFE_BRIDGE_DESIGN.md` | SAFE bridge convergence design | PASS |
| VE-003 | `VERIFICATION_EVIDENCE_003_SAFE_BRIDGE_CONVERGENCE.md` | SAFE bridge implementation and compatibility | PASS |
| VE-004 | `VERIFICATION_EVIDENCE_004_PROVIDER_CONTRACT.md` | Shared Ollama and LM Studio contract | PASS |
| VE-005 | `VERIFICATION_EVIDENCE_005_PROVIDER_DEVELOPMENT_KIT.md` | PDK and certification workflow | PASS |
| VE-006 | `VERIFICATION_EVIDENCE_006_REFERENCE_PROVIDER.md` | Reference provider certification | PASS |
| VE-007 | `VERIFICATION_EVIDENCE_007_PLATFORM_EXTENSION_VALIDATION.md` | End-to-end extension model validation | PASS |

## Architecture and Planning

- `README.md`
- `PHASE2A_ARCHITECTURE.md`
- `PHASE2A_IMPLEMENTATION_PLAN.md`
- `SAFE_BRIDGE_CONVERGENCE_DESIGN.md`
- `PHASE2A_STATUS.md`
- `RISKS_AND_BLOCKERS.md`

## Provider Extension Package

- `PROVIDER_CONTRACT.md`
- `PROVIDER_DEVELOPMENT_KIT.md`
- `PROVIDER_IMPLEMENTATION_GUIDE.md`
- `PROVIDER_CERTIFICATION_CHECKLIST.md`
- `PROVIDER_TEMPLATE.md`
- `REFERENCE_PROVIDER_GUIDE.md`
- `PLATFORM_EXTENSION_VALIDATION.md`

## Executable Evidence

- `tests/provider_contract.py`
- `tests/provider_contract_mixin.py`
- `tests/test_phase2a_provider_contract.py`
- `tests/test_phase2a_safe_bridge_convergence.py`
- `tests/test_phase2a_reference_provider.py`
- `templates/provider_template.py`
- `Phase1B/local_ai/reference_provider.py`

## Evidence Coverage

The indexed evidence covers:

- authorization and scope;
- architecture and public contracts;
- SAFE bridge behavior;
- provider neutrality;
- health and model discovery;
- request and response contracts;
- diagnostics and error handling;
- capability declarations;
- provenance restrictions;
- PDK usability;
- extension repeatability;
- regression results;
- LOCKED component compliance.

## Completeness Statement

All implemented Phase 2A milestones through M6 have corresponding evidence.
`P2A-B003` is deferred as non-blocking for evidence-driven reassessment in
Phase 2B. Product Owner acceptance was recorded on 2026-07-09. The Phase 2A
evidence package is complete.
